Pharma, Physicians, Policy and politics 11/13/07 Pharma, Physicians, Policy and politics 11/13/07 Genentech tries to allay the concerns of ophthalmologists Read More Podcast, Policy and politics, Research, Uncategorized 11/12/07 Podcast, Policy and politics, Research, Uncategorized 11/12/07 BIO's Alan Eisenberg advocates SBIR grant eligibility for companies majority owned by venture capitalists (transcript) Read More Hospitals, International, Medical travel/medical..., Policy and politics 11/5/07 Hospitals, International, Medical travel/medical..., Policy and politics 11/5/07 Dubai Healthcare City or Hadassah Medical Center? Read More International, Policy and politics 11/2/07 International, Policy and politics 11/2/07 Glass houses award Read More Pharma, Policy and politics 11/1/07 Pharma, Policy and politics 11/1/07 Interview with Genentech re: Avastin distribution changes Read More Podcast, Policy and politics, Research 10/31/07 Podcast, Policy and politics, Research 10/31/07 BIO's Alan Eisenberg advocates SBIR grant eligibility for companies majority owned by venture capitalists Read More Pharma, Policy and politics 10/31/07 Pharma, Policy and politics 10/31/07 Avastin update: Still seeking answers Read More Economics, Pharma, Policy and politics 10/30/07 Economics, Pharma, Policy and politics 10/30/07 Latest developments in the Avastin/Lucentis saga raise new questions Read More Policy and politics 10/29/07 Policy and politics 10/29/07 If only US health care could be more like the Patriots (or even the Red Sox) and less like the Yankees Read More Amusements, Policy and politics 10/29/07 Amusements, Policy and politics 10/29/07 Was President Clinton a Republican? Read More Policy and politics, Research 10/26/07 Policy and politics, Research 10/26/07 Giving personalized medicine a bad name Read More e-health, Policy and politics 10/24/07 e-health, Policy and politics 10/24/07 IBM shares wellness with the kids Read More Pharma, Policy and politics 10/4/07 Pharma, Policy and politics 10/4/07 PG-13 for drugs Read More Amusements, Policy and politics 9/26/07 Amusements, Policy and politics 9/26/07 Who cares? Read More Amusements, Policy and politics, Uncategorized 9/26/07 Amusements, Policy and politics, Uncategorized 9/26/07 Richard, we missed you Read More Economics, Policy and politics 9/24/07 Economics, Policy and politics 9/24/07 Book recommendation: Fixing American Healthcare Read More Blogs, Economics, Policy and politics 9/11/07 Blogs, Economics, Policy and politics 9/11/07 Cavalcade of Risk #34 Read More Physicians, Policy and politics 9/11/07 Physicians, Policy and politics 9/11/07 The role of retail clinics Read More Pharma, Policy and politics 9/6/07 Pharma, Policy and politics 9/6/07 Look for a nice bump in investigator initiated trials Read More Pharma, Policy and politics 9/6/07 Pharma, Policy and politics 9/6/07 No biogeneric legislation this year Read More Newer Posts Older Posts
Pharma, Physicians, Policy and politics 11/13/07 Pharma, Physicians, Policy and politics 11/13/07 Genentech tries to allay the concerns of ophthalmologists Read More
Podcast, Policy and politics, Research, Uncategorized 11/12/07 Podcast, Policy and politics, Research, Uncategorized 11/12/07 BIO's Alan Eisenberg advocates SBIR grant eligibility for companies majority owned by venture capitalists (transcript) Read More
Hospitals, International, Medical travel/medical..., Policy and politics 11/5/07 Hospitals, International, Medical travel/medical..., Policy and politics 11/5/07 Dubai Healthcare City or Hadassah Medical Center? Read More
International, Policy and politics 11/2/07 International, Policy and politics 11/2/07 Glass houses award Read More
Pharma, Policy and politics 11/1/07 Pharma, Policy and politics 11/1/07 Interview with Genentech re: Avastin distribution changes Read More
Podcast, Policy and politics, Research 10/31/07 Podcast, Policy and politics, Research 10/31/07 BIO's Alan Eisenberg advocates SBIR grant eligibility for companies majority owned by venture capitalists Read More
Pharma, Policy and politics 10/31/07 Pharma, Policy and politics 10/31/07 Avastin update: Still seeking answers Read More
Economics, Pharma, Policy and politics 10/30/07 Economics, Pharma, Policy and politics 10/30/07 Latest developments in the Avastin/Lucentis saga raise new questions Read More
Policy and politics 10/29/07 Policy and politics 10/29/07 If only US health care could be more like the Patriots (or even the Red Sox) and less like the Yankees Read More
Amusements, Policy and politics 10/29/07 Amusements, Policy and politics 10/29/07 Was President Clinton a Republican? Read More
Policy and politics, Research 10/26/07 Policy and politics, Research 10/26/07 Giving personalized medicine a bad name Read More
e-health, Policy and politics 10/24/07 e-health, Policy and politics 10/24/07 IBM shares wellness with the kids Read More
Amusements, Policy and politics, Uncategorized 9/26/07 Amusements, Policy and politics, Uncategorized 9/26/07 Richard, we missed you Read More
Economics, Policy and politics 9/24/07 Economics, Policy and politics 9/24/07 Book recommendation: Fixing American Healthcare Read More
Blogs, Economics, Policy and politics 9/11/07 Blogs, Economics, Policy and politics 9/11/07 Cavalcade of Risk #34 Read More
Physicians, Policy and politics 9/11/07 Physicians, Policy and politics 9/11/07 The role of retail clinics Read More
Pharma, Policy and politics 9/6/07 Pharma, Policy and politics 9/6/07 Look for a nice bump in investigator initiated trials Read More
Pharma, Policy and politics 9/6/07 Pharma, Policy and politics 9/6/07 No biogeneric legislation this year Read More
